GSK analgesics signed JV with Novartis.
Obj meetings with GSK A. scheduled this quarter.
![]()
Novartis. Powerhouse. Diclofenac (Voltaren) a product they have.
![]()
![]()
OBJ 16/9/2005. Clinical test on our tech increasing uptake of Novartis' diclofenac (Voltaren).
Yielded great results.
A decade later. The opportunity presents.
![]()
![]()
- Forums
- ASX - By Stock
- WFL
- Novartis.
Novartis.
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
HCH
Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable